Access
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
News Analysis
Nature Reviews Drug Discovery 5, 453–454 (1 June 2006) | doi:10.1038/nrd2069
Ranolazine
&
Abstract
Ranolazine (Ranexa; Cardiovascular Therapeutics) was approved by the US FDA for the treatment of chronic angina in January 2006. It is the first drug in a new class for treating this condition to be approved in the United States in more than 20 years.
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
